Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-31

FDA Approved: OXYMORPHONE HYDROCHLORIDE — Supplemental Application (KVK-Tech, Inc.)

View source ↗

Summary

FDA approved a supplemental ANDA for oxymorphone hydrochloride from KVK-Tech, Inc., authorizing its generic product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxymorphone hydrochloride (Oxymorphone hydrochloride)

Snippet

SUPPL AP for OXYMORPHONE HYDROCHLORIDE (OXYMORPHONE HYDROCHLORIDE)